PRESS RELEASE published on 05/15/2025 at 17:52, 1 year 4 months ago Commerzbank Annual General Meeting approves all agenda items Commerzbank AG's Annual General Meeting approves 65 cents per share dividend and share buybacks, elects new Supervisory Board members. CEO and Chairman highlight bank's strategic growth plan and financial strength Annual General Meeting Dividend Supervisory Board Share Buybacks Commerzbank
PRESS RELEASE published on 05/15/2025 at 17:49, 1 year 4 months ago Commerzbank Annual General Meeting approves all agenda items Commerzbank's Annual General Meeting approves dividend and share buybacks, elects new Supervisory Board members, and reinforces commitment to stakeholders amid economic challenges Annual General Meeting Dividend Supervisory Board Share Buybacks Commerzbank
BRIEF published on 05/09/2025 at 07:09, 1 year 4 months ago Commerzbank Reports Strong First Quarter Results Share Buyback Commerzbank Quarterly Results AI Strategy Commission Income
BRIEF published on 05/09/2025 at 07:09, 1 year 4 months ago Commerzbank annonce de solides résultats au premier trimestre Rachat D'actions Commerzbank Résultats Trimestriels Stratégie D'IA Revenus De Commission
BRIEF published on 05/09/2025 at 07:05, 1 year 4 months ago Commerzbank Reports Strong Q1 Results with Significant Income Growth Revenue Growth Commerzbank Quarterly Results Cost-income Ratio AI Initiatives
BRIEF published on 05/09/2025 at 07:05, 1 year 4 months ago Commerzbank annonce de solides résultats au premier trimestre avec une croissance significative des revenus Commerzbank Croissance Des Revenus Résultats Trimestriels Initiatives En Matière D'IA Rapport Coûts-revenus
PRESS RELEASE published on 05/09/2025 at 07:04, 1 year 4 months ago Commerzbank with strong quarterly result – Growth in net commission income continues Commerzbank reports strong Q1 results with record €1.2bn operating result and double-digit RoTE. Steps forward in digital transformation and AI integration AI Integration Digital Transformation Commerzbank Operating Result Q1 Results
PRESS RELEASE published on 05/09/2025 at 07:00, 1 year 4 months ago Commerzbank with strong quarterly result – Growth in net commission income continues Commerzbank reports strong quarterly results with record operating result and net commission income growth. Outlook confirmed for full year 2025 Outlook Commerzbank Quarterly Results Net Commission Income Financial Year 2025
BRIEF published on 04/30/2025 at 19:05, 1 year 4 months ago Ecoslops Publie son Rapport Financier Annuel 2024 Euronext Growth Rapport Financier 2024 Ecoslops Micro-raffinage
BRIEF published on 04/30/2025 at 19:05, 1 year 4 months ago Ecoslops Publishes its 2024 Annual Financial Report Financial Report Euronext Growth 2024 Ecoslops Micro-refining
Published on 09/21/2026 at 15:45, 2 hours 12 minutes ago Datavault AI and Cutting-Edge Sports Management Announce Dream Bowl XV at AT&T Stadium and Launch First-of-Its-Kind Bowl Combine
Published on 09/21/2026 at 14:20, 3 hours 37 minutes ago Doctor's Choice(R) Clinically-Proven Scrubs Launching on Amazon Canada
Published on 09/21/2026 at 14:05, 3 hours 52 minutes ago Winners of this Year's Semmelweis-Richter International Journalism Award Announced
Published on 09/21/2026 at 14:00, 3 hours 57 minutes ago Dateline Files Motion to Resume Operations at Colosseum
Published on 09/21/2026 at 13:45, 4 hours 12 minutes ago Nine Mile Metals DDH WD-26-11 Intersects 2 High Grade VMS Zones Over 27.6M Including 3.08% CU-EQ Over 10.70M, 3.27% CU-EQ Over 9.30M and 4.30% CU-EQ Over 5.0M
Published on 09/21/2026 at 17:45, 12 minutes ago EQS-Adhoc: Airbus reports share buyback transactions 11-18 September 2026
Published on 09/21/2026 at 17:45, 12 minutes ago Charwood Energy poursuit sur un rythme de croissance élevé. Chiffre d’affaires semestriel en hausse de +43 % à 5,6 M€.
Published on 09/21/2026 at 17:45, 12 minutes ago Charwood Energy continues to grow at a strong pace. H1 revenue up +43% to €5.6m.
Published on 09/21/2026 at 17:00, 57 minutes ago Menarini Group and NewAmsterdam Pharma Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
Published on 09/21/2026 at 17:46, 11 minutes ago WEB SA - STATUTORY HALF-YEAR RESULTS AS OF 30/06/2026
Published on 09/21/2026 at 17:46, 11 minutes ago WEB SA - RESULTATS SEMESTRIELS STATUTAIRES AU 30/06/2026
Published on 09/21/2026 at 07:00, 10 hours 57 minutes ago Peugeot Invest takes a stake in Mérieux NutriSciences
